{"schema_version":"alpha-company-profile-public-v2","slug":"boundless-bio-inc","canonical_url":"https://registry.alpha.ac/companies/boundless-bio-inc","published_on":"2026-09-13T04:46:54.283359+00:00","last_reviewed_on":"2026-09-13T04:46:54.283359+00:00","identity":{"legal_name":"Boundless Bio, Inc.","display_name":"Boundless Bio, Inc.","headline":"Boundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors.","description":"Boundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors. Their core strategy involves targeting extrachromosomal DNA (ecDNA). The company's lead product candidate, BBI-355, an orally administered inhibitor of checkpoint kinase 1 (CHK1), is currently in Phase 1/2 clinical trials for patients suffering from oncogene amplified cancers. Additionally, Boundless ","ten_second_view":"This Company Profile publishes only Alpha's canonical identity and evidence-backed public leadership records. Unavailable fields are not inferred.","legal_form":"Not publicly asserted","incorporation":"Not publicly asserted","headquarters":"US","headquarters_address":{"locality":"Not publicly asserted","region":null,"country":"US"},"operating_presence":["US"],"website":"","cik":"0001782303","logo":"https://cdn.brandfetch.io/ticker/bold/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","logo_source":"brandfetch","profile_mark":{"src":"https://cdn.brandfetch.io/ticker/bold/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","alt":"Boundless Bio, Inc. logo","width":256,"height":256,"source":"brandfetch"}},"entity_status":{"ownership_type":"unknown","listing_status":"listed","label":"Public listing published","explanation":"The canonical public record includes at least one active security listing.","source_id":"alpha-canonical-company-record","reviewed_on":"2026-09-13T04:46:54.283359+00:00"},"security_listings":[{"ticker":"BOLD","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true,"source_id":"alpha-canonical-company-record"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market data is not published in this Company Profile."},"profile_tags":["Canonical identity","Public leadership"],"trust_summary":"Canonical identity published; broader company intelligence is not asserted.","facts":[{"label":"Legal name","value":"Boundless Bio, Inc.","source_id":"alpha-canonical-company-record"},{"label":"Country","value":"US","source_id":"alpha-canonical-company-record"},{"label":"Sector","value":"Healthcare","source_id":"alpha-canonical-company-record"},{"label":"Industry","value":"Biotechnology","source_id":"alpha-canonical-company-record"}],"operating_model":{"eyebrow":"Operating record","title":"Published operating structure","units":[]},"governance":{"summary":"Only current, confirmed leadership roles with public evidence are included in the canonical projection.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","disclosures":[]},"alpha_opinion":{"status":"Not published","label":"No Alpha opinion published","explanation":"This identity record is not an Alpha rating, score, or investment opinion."},"report":{"status":"Not published","label":"No governed report published","explanation":"No governed company report is attached to this profile.","href":null},"actions":[],"related_records":[],"evidence":[{"id":"alpha-canonical-company-record","label":"Alpha canonical company public projection","href":"/api/public/companies/boundless-bio-inc","source_type":"canonical_identity","supports":["Company identity","Published leadership","Entity status boundary"],"status":"published","reviewed_on":"2026-09-13T04:46:54.283359+00:00"}],"permissions":[{"label":"Public retrieval","allowed":true},{"label":"Agent retrieval","allowed":true},{"label":"Redistribution","allowed":false},{"label":"Model training","allowed":false},{"label":"Relationship pathfinding","allowed":false},{"label":"Direct contact","allowed":false}],"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":12,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":12,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":2,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":12,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":12,"corroborated_claims":0,"sources":2,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-09-13T04:46:54.283359+00:00","observed_at":"2026-09-13T04:46:54.283359+00:00","freshness_days":0}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"company","slug":"boundless-bio-inc","canonical_url":"https://registry.alpha.ac/companies/boundless-bio-inc"},"publication":{"published_at":"2026-09-13T04:46:54.283359+00:00","last_reviewed_at":"2026-09-13T04:46:54.283359+00:00","as_of":"2026-09-13T04:46:54.283359+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/boundless-bio-inc","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/companies/boundless-bio-inc","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/companies/boundless-bio-inc.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}},"canonical_profile":{"schema_version":"alpha-company-profile-public-v1","slug":"boundless-bio-inc","canonical_url":"https://registry.alpha.ac/companies/boundless-bio-inc","as_of":"2026-09-13T04:46:54.283359+00:00","last_reviewed_at":"2026-09-13T04:46:54.283359+00:00","identity":{"legal_name":"Boundless Bio, Inc.","display_name":"Boundless Bio, Inc.","description":"Boundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors. Their core strategy involves targeting extrachromosomal DNA (ecDNA). The company's lead product candidate, BBI-355, an orally administered inhibitor of checkpoint kinase 1 (CHK1), is currently in Phase 1/2 clinical trials for patients suffering from oncogene amplified cancers. Additionally, Boundless ","jurisdiction":null,"country":"US","sector":"Healthcare","industry":"Biotechnology","website":null,"website_provenance":null,"logo_url":null,"logo_media":null,"status":"active","cik":"0001782303","entity_subtype":null,"legal_entity_status":null},"security_listings":[{"mic":"XNAS","ticker":"BOLD","currency":null,"exchange":"NASDAQ","sort_key":0,"valid_to":null,"confidence":0.95,"is_primary":true,"listing_id":"5a9ab2e9-2aee-486c-86dc-7bc223a776ad","source_url":"https://www.sec.gov/files/company_tickers_exchange.json","valid_from":null,"observed_at":"2026-07-11T00:28:32+00:00","source_name":"sec_company_tickers_exchange","source_tier":1,"exchange_name":"NASDAQ","security_type":"equity","listing_status":"active","last_checked_at":"2026-09-02T01:48:40.989053+00:00"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market observations are unpublished. Listing identity remains available from the governed source set."},"index_memberships":[],"index_membership_history":[],"index_membership_contract":{"schema_version":"alpha-index-membership-public-v1","as_of_date":"2026-09-13","tracked_universe_complete":false,"permissions":{"public_retrieval":true,"agent_retrieval":false,"redistribution":false,"model_training":false},"limitations":["Only source-backed memberships with an explicit public redistribution basis are returned.","Absence from Alpha tracked indices does not establish absence from every market index.","Provider announcements and effective membership are represented as distinct states.","Alpha AI 100 is not published as a current public index membership."]},"leadership":{"board":[{"person_slug":"christine-brennan-ph-d","display_name":"Christine Brennan, Ph.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Boundless Bio, Inc. DEF 14A 2025-04-29","source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-04-29","last_checked_at":"2026-04-28T23:34:02.069+00:00"},"headshot_url":null},{"person_slug":"james-christensen-ph-d","display_name":"James Christensen, Ph.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Boundless Bio, Inc. DEF 14A 2025-04-29","source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-04-29","last_checked_at":"2026-04-28T23:34:02.069+00:00"},"headshot_url":null},{"person_slug":"jennifer-lew","display_name":"Jennifer Lew","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Boundless Bio, Inc. DEF 14A 2025-04-29","source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-04-29","last_checked_at":"2026-04-28T23:34:02.069+00:00"},"headshot_url":null},{"person_slug":"jonathan-e-lim-m-d-2","display_name":"Jonathan E. Lim, M.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2018-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Boundless Bio, Inc. DEF 14A 2025-04-29","source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-04-29","last_checked_at":"2026-04-28T23:34:02.069+00:00"},"headshot_url":null},{"person_slug":"kristina-burow","display_name":"Kristina Burow","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Boundless Bio, Inc. DEF 14A 2025-04-29","source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-04-29","last_checked_at":"2026-04-28T23:34:02.069+00:00"},"headshot_url":null},{"person_slug":"nancy-whiting-pharm-d","display_name":"Nancy Whiting, Pharm.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Boundless Bio, Inc. DEF 14A 2025-04-29","source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-04-29","last_checked_at":"2026-04-28T23:34:02.069+00:00"},"headshot_url":null},{"person_slug":"zachary-d-hornby","display_name":"Zachary D. Hornby","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2019-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Boundless Bio, Inc. DEF 14A 2025-04-29","source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-04-29","last_checked_at":"2026-04-28T23:34:02.069+00:00"},"headshot_url":null}],"executives":[],"coverage":{"schema_version":"alpha-leadership-coverage-v1","board_roster_scope":"def_14a_current_directors","executive_roster_scope":"NOT_ASSERTED","neo_set_status":"NOT_ASSERTED","board_roster_complete":false,"neo_set_complete":false,"notes":["Empty executives is NOT_ASSERTED, not a complete named-executive-officer set.","Form 4 occupancy is not a DEF 14A board.","Unconfirmed current sec_proxy DEF 14A directors may project. Confirmed is not required.","Unconfirmed current executives with first-party issuer evidence (source_url + effective date) may project.","Company-page directors do not require people.public_profile_enabled.","Completeness compares the latest first-party roster with the public projection; a source older than 180 days is STALE.","Do not remap HONA to HON 0000773840. Do not merge XOM 0000034088 with 0002115436.","Person match is projection-only. Name-only Person merges are forbidden."],"completeness":{"reasons":["NO_LEADERSHIP_SOURCE"],"board_completeness":"NOT_REVIEWED","completeness_schema":"alpha-leadership-completeness-v1","executive_team_completeness":"NOT_REVIEWED"},"parser_bleed_excluded":true,"former_titles_excluded":true,"identity_merge_forbidden":true,"form4_occupancy_is_not_board":true}},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"structured_data":{"@context":["https://schema.org",{"alpha":"https://alpha.ac/ns/","indexMembership":"alpha:indexMembership","indexProvider":"alpha:indexProvider","indexMembershipStatus":"alpha:indexMembershipStatus","indexEffectiveDate":"alpha:indexEffectiveDate","indexAnnouncementDate":"alpha:indexAnnouncementDate","indexRemovalDate":"alpha:indexRemovalDate","lastVerifiedAt":"alpha:lastVerifiedAt","verificationStatus":"alpha:verificationStatus","evidence":"alpha:evidence"}],"@type":"ProfilePage","@id":"https://registry.alpha.ac/companies/boundless-bio-inc#profile","url":"https://registry.alpha.ac/companies/boundless-bio-inc","dateModified":"2026-09-13T04:46:54.283359+00:00","mainEntity":{"@type":"Organization","@id":"https://registry.alpha.ac/companies/boundless-bio-inc#organization","legalName":"Boundless Bio, Inc.","name":"Boundless Bio, Inc.","description":"Boundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors. Their core strategy involves targeting extrachromosomal DNA (ecDNA). The company's lead product candidate, BBI-355, an orally administered inhibitor of checkpoint kinase 1 (CHK1), is currently in Phase 1/2 clinical trials for patients suffering from oncogene amplified cancers. Additionally, Boundless ","url":"https://registry.alpha.ac/companies/boundless-bio-inc","addressCountry":"US","indexMembership":[],"member":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2022-01-01","member":{"@type":"Person","name":"Christine Brennan, Ph.D.","url":"https://registry.alpha.ac/people/christine-brennan-ph-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2023-01-01","member":{"@type":"Person","name":"James Christensen, Ph.D.","url":"https://registry.alpha.ac/people/james-christensen-ph-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2022-01-01","member":{"@type":"Person","name":"Jennifer Lew","url":"https://registry.alpha.ac/people/jennifer-lew"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2018-01-01","member":{"@type":"Person","name":"Jonathan E. Lim, M.D.","url":"https://registry.alpha.ac/people/jonathan-e-lim-m-d-2"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2019-01-01","member":{"@type":"Person","name":"Kristina Burow","url":"https://registry.alpha.ac/people/kristina-burow"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2023-01-01","member":{"@type":"Person","name":"Nancy Whiting, Pharm.D.","url":"https://registry.alpha.ac/people/nancy-whiting-pharm-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2019-01-01","member":{"@type":"Person","name":"Zachary D. Hornby","url":"https://registry.alpha.ac/people/zachary-d-hornby"}}]},"mainEntityOfPage":"https://registry.alpha.ac/companies/boundless-bio-inc"}},"canonical_source":"aegis_canonical"}